Genpact Limited Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect
Genpact Limited (G) reported Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect of -$296.60 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Change in Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect · last filed 2026-08-07
- Genpact Limited cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2026-03-31 was -$259.31M.
- Genpact Limited cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2025-03-31 was -$84.33M.
- Genpact Limited cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2024-03-31 was -$98.43M.
- Genpact Limited cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2023-03-31 was -$108.90M.
- Genpact Limited cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2025 was $210.55M, a 148.82% increase from fiscal 2024.
- Genpact Limited cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2024 was $84.62M.
- Genpact Limited cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2023 was -$71.13M.
- Genpact Limited cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2022 was -$164.32M, a 168.86% decline from fiscal 2021.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$296.60M 10-Q · filed 2026-08-07 | |||
| 2026-03-31 | -$259.31M 10-Q · filed 2026-05-08 | |||
| 2025-12-31 | $210.55M 10-K · filed 2026-02-26 | |||
| 2025-09-30 | $86.89M 10-Q · filed 2025-11-07 | |||
| 2025-06-30 | $6.71M 10-Q · filed 2026-08-07 | |||
| 2025-03-31 | -$84.33M 10-Q · filed 2026-05-08 | |||
| 2024-12-31 | $84.62M 10-K · filed 2026-02-26 | |||
| 2024-09-30 | $440.05M 10-Q · filed 2025-11-07 | |||
| 2024-06-30 | $341.61M 10-Q · filed 2025-08-11 | |||
| 2024-03-31 | -$98.43M 10-Q · filed 2025-05-12 | |||
| 2023-12-31 | -$71.13M 10-K · filed 2026-02-26 | |||
| 2023-09-30 | -$99.43M 10-Q · filed 2024-11-12 | |||
| 2023-06-30 | -$166.26M 10-Q · filed 2024-08-09 | |||
| 2023-03-31 | -$108.90M 10-Q · filed 2024-05-10 | |||
| 2022-12-31 | -$164.32M 10-K · filed 2025-03-03 | |||
| 2022-09-30 | -$294.39M 10-Q · filed 2023-11-09 | |||
| 2022-06-30 | -$398.20M 10-Q · filed 2023-08-09 | |||
| 2022-03-31 | -$30.59M 10-Q · filed 2023-05-10 | |||
| 2021-12-31 | $238.65M 10-K · filed 2024-02-29 | |||
| 2021-09-30 | $259.12M 10-Q · filed 2022-11-09 | |||
| 2021-06-30 | $78.30M 10-Q · filed 2022-08-09 | |||
| 2021-03-31 | -$31.27M 10-Q · filed 2022-05-10 | |||
| 2020-12-31 | $225.90M 10-K · filed 2023-03-01 | |||
| 2020-09-30 | $367.72M 10-Q · filed 2021-11-09 | |||
| 2020-06-30 | $438.03M 10-Q · filed 2021-08-09 | |||
| 2020-03-31 | -$44.34M 10-Q · filed 2020-05-11 | |||
| 2019-12-31 | $110.42M 10-K · filed 2022-03-01 | |||
| 2019-09-30 | $101.10M 10-Q · filed 2019-11-08 | |||
| 2019-03-31 | -$38.08M 10-Q · filed 2020-05-11 | |||
| 2018-12-31 | -$71.73M 10-K · filed 2020-03-02 | |||
| 2018-09-30 | -$49.02M 10-Q · filed 2019-11-08 | |||
| 2017-12-31 | $44.28M 10-K · filed 2020-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FTI CONSULTING, INC (FCN) | United States | $3.602B | 16.33 |
| EXPONENT INC (EXPO) | United States | $3.065B | 26.46 |
| Huron Consulting Group Inc. (HURN) | United States | $2.557B | 20.80 |
| Booz Allen Hamilton Holding Corp (BAH) | United States | $8.878B | 9.38 |
| Astrana Health, Inc. (ASTH) | United States | $1.921B | 63.77 |
| ICF International, Inc. (ICFI) | United States | $1.490B | 14.74 |
| Bowman Consulting Group Ltd. (BWMN) | United States | $0.738B | 68.09 |
| Onterris, Inc. (ONT) | United States | $0.590B | -63.69 |
| Public Policy Holding Company, Inc. (PPHC) | United States | $0.347B | |
| Aeries Technology, Inc. (AERT) | Cayman Islands | $0.336B | -0.00 |